TERN
USDTerns Pharmaceuticals Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$15.500
Максимум
$18.740
Минимум
$15.500
Объем
4.37M
Фундаментальные показатели компании
Рыночная капитализация
1.5B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.85M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Truist Securities Reiterates Buy on Terns Pharma, Raises Price Target to $28
Truist Securities analyst Srikripa Devarakonda reiterates Terns Pharma with a Buy and raises the price target from $20 to $28.
BMO Capital Maintains Outperform on Terns Pharma, Raises Price Target to $22
BMO Capital analyst Etzer Darout maintains Terns Pharma with a Outperform and raises the price target from $15 to $22.
Barclays Maintains Overweight on Terns Pharma, Raises Price Target to $27
Barclays analyst Etzer Darout maintains Terns Pharma with a Overweight and raises the price target from $14 to $27.
HC Wainwright & Co. Upgrades Terns Pharma to Buy, Announces $20 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado upgrades Terns Pharma from Neutral to Buy and announces $20 price target.
William Blair Upgrades Terns Pharma to Outperform
William Blair analyst Andy Hsieh upgrades Terns Pharma from Market Perform to Outperform.
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the stock to Outperform.
Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annual Meeting
Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host investor update call on
Связанные акции
KTH
Structures Products Cp 8% CorTS Issued by Peco Energy Cap Tr II Preferred Stock
EML
Eastern Company (The)
AORT
Artivion Inc.
CNNE
Cannae Holdings Inc.
RBCP
RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.